Immunochemotherapy against colon cancer by gene transfer of interleukin-12 in combination with oxaliplatin

被引：12
作者：
Hernandez-Alcoceba, Ruben [1 ]
Berraondo, Pedro [1 ]
机构：
[1] Univ Navarra, Div Gene Therapy & Hepatol, CIMA, Fdn Appl Med Res, E-31080 Pamplona, Spain
来源：
ONCOIMMUNOLOGY | 2012年 / 1卷 / 01期
关键词：
interleukin-12; oxaliplatin; colorectal cancer; liver; adenovirus; SUPPRESSOR-CELLS; IMMUNE-SYSTEM; EXPRESSION;
D O I：
10.4161/onci.1.1.17930
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Using a murine model of liver metastases, we found that oxaliplatin can enhance the immunostimulatory effect of interleukin-12 delivered by an adenoviral vector. A shift toward a favorable immune microenvironment was observed in tumors, with a relative increase in CD8(+) T cells vs. T regulatory and myeloid-derived suppressor cells.
引用
收藏
页码：97 / 99
页数：3
相关论文
共 50 条
  • [1] Gene therapy of cancer with interleukin-12
    Mazzolini, G
    Prieto, J
    Melero, I
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (24) : 1981 - 1991
  • [2] Folate-Modified Lipoplexes Delivering the Interleukin-12 Gene for Targeting Colon Cancer Immunogene Therapy
    Luo, Min
    Liang, Xiao
    Luo, Shun-Tao
    Wei, Xia-Wei
    Liu, Ting
    Ren, Jun
    Ma, Cui-Cui
    Yang, Yu-Han
    Wang, Bi-Lan
    Liu, Li
    Song, Xiang-Rong
    He, Zhi-Yao
    Wei, Yu-Quan
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2015, 11 (11) : 2011 - 2023
  • [3] Genetic heterogeneity in the toxicity to systemic adenoviral gene transfer of interleukin-12
    Mazzolini, G
    Narvaiza, I
    Pérez-Diez, A
    Rodriguez-Calvillo, M
    Qian, C
    Sangro, B
    Ruiz, J
    Prieto, J
    Melero, I
    GENE THERAPY, 2001, 8 (04) : 259 - 267
  • [4] Genetic heterogeneity in the toxicity to systemic adenoviral gene transfer of interleukin-12
    G Mazzolini
    I Narvaiza
    A Pérez-Diez
    M Rodriguez-Calvillo
    C Qian
    B Sangro
    J Ruiz
    J Prieto
    I Melero
    C Quian
    Gene Therapy, 2001, 8 : 259 - 267
  • [5] Co-Delivery of Paclitaxel and Interleukin-12 Regulating Tumor Microenvironment for Cancer Immunochemotherapy
    Hu, Qian
    Shang, Lihuan
    Wang, Mengmeng
    Tu, Kun
    Hu, Mei
    Yu, Yulin
    Xu, Mingwang
    Kong, Li
    Guo, Yuanyuan
    Zhang, Zhiping
    ADVANCED HEALTHCARE MATERIALS, 2020, 9 (10)
  • [6] Interleukin-12 Gene Polymorphism and Cervical Cancer Risk
    Tamandani, Dor Mohammad Kordi
    Shekari, Mohammad
    Suri, V.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (05): : 524 - 528
  • [7] Antitumor activity of interleukin-12 against murine bladder cancer
    Eto, M
    Harada, M
    Tamada, K
    Tokuda, N
    Koikawa, Y
    Nakamura, M
    Nomoto, K
    Naito, S
    JOURNAL OF UROLOGY, 2000, 163 (05) : 1549 - 1552
  • [8] Interleukin-12 inhibits the survival of human colon cancer stem cells in vitro and their tumor initiating capacity in mice
    Yin, Xiao-ling
    Wang, Ning
    Wei, Xing
    Xie, Gan-feng
    Li, Jian-jun
    Liang, Hou-jie
    CANCER LETTERS, 2012, 322 (01) : 92 - 97
  • [9] Interleukin-2, melatonin and interleukin-12 as a possible neuroimmune combination in the biotherapy of cancer
    Lissoni, P
    Pittalis, S
    Rovelli, F
    Vigore, L
    Roselli, MG
    Brivio, F
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 1995, 9 (02) : 63 - 66
  • [10] Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12
    Guillermo Mazzolini
    Cheng Qian
    Xiaoming Xie
    Yonglian Sun
    Juan J Lasarte
    Marek Drozdzik
    Jesús Prieto
    Cancer Gene Therapy, 1999, 6 : 514 - 522
12345